[{"Assets_0_Q3_USD":390615000.0,"CommonStockSharesOutstanding_0_Q3_shares":66155613.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-26573000.0,"NetIncomeLoss_1_Q3_USD":-10917000.0,"NetIncomeLoss_3_Q3_USD":-26854000.0,"StockholdersEquity_0_Q3_USD":339186000.0,"Ticker":"NGM","CIK":"1426332","name":"NGM BIOPHARMACEUTICALS INC","OfficialName":"NGM Biopharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1227500649.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20191112"}]